| Mrs Laura M Moore, MD | |
|
3841 Piper Street, Suite T4-054, Anchorage, AK 99508 | |
| (907) 562-6228 | |
| (907) 562-6868 |
| Full Name | Mrs Laura M Moore |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 27 Years |
| Location | 3841 Piper Street, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710977822 | NPI | - | NPPES |
| 12268 | Other | MT | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 101511 (Alaska) | Primary |
| 208000000X | Pediatrics | 101511 (Alaska) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Asthma And Immunology Center Of Alaska Llc | 6507858081 | 6 |
News Archive
Case Western Reserve University (CWRU) School of Medicine proudly announces the establishment of the CWRU Prevention Research Center for Healthy Neighborhoods (PRCHN), a collaborative research center to address common health issues faced in disadvantaged urban neighborhoods in and around Greater Cleveland.
Researchers at the La Jolla Institute for Allergy & Immunology have proven - for the first time in human tissues - the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
April is Cesarean Awareness Month and the American College of Nurse-Midwives (ACNM) is renewing its call for Congressional hearings into the nation's rising Cesarean section rate and the impact on women's health and the overall health care system. Recent data indicates that as many 4 women in 10 gave birth by Cesarean in 2003, with an increasing percentage of first-time Cesareans being performed with no medical indication.
A major new international study published in the Journal of Hypertension has challenged traditional thinking by revealing that the thiazide-like diuretic indapamide SR (Natrilix SR) has equivalent efficacy to enalapril in reducing microalbuminuria (MA) in patients with type 2 diabetes.
› Verified 9 days ago
| Entity Name | Allergy Asthma And Immunology Center Of Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942382874 PECOS PAC ID: 6507858081 Enrollment ID: O20040402000602 |
News Archive
Case Western Reserve University (CWRU) School of Medicine proudly announces the establishment of the CWRU Prevention Research Center for Healthy Neighborhoods (PRCHN), a collaborative research center to address common health issues faced in disadvantaged urban neighborhoods in and around Greater Cleveland.
Researchers at the La Jolla Institute for Allergy & Immunology have proven - for the first time in human tissues - the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
April is Cesarean Awareness Month and the American College of Nurse-Midwives (ACNM) is renewing its call for Congressional hearings into the nation's rising Cesarean section rate and the impact on women's health and the overall health care system. Recent data indicates that as many 4 women in 10 gave birth by Cesarean in 2003, with an increasing percentage of first-time Cesareans being performed with no medical indication.
A major new international study published in the Journal of Hypertension has challenged traditional thinking by revealing that the thiazide-like diuretic indapamide SR (Natrilix SR) has equivalent efficacy to enalapril in reducing microalbuminuria (MA) in patients with type 2 diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Laura M Moore, MD 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Ph: (907) 562-6228 | Mrs Laura M Moore, MD 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Ph: (907) 562-6228 |
News Archive
Case Western Reserve University (CWRU) School of Medicine proudly announces the establishment of the CWRU Prevention Research Center for Healthy Neighborhoods (PRCHN), a collaborative research center to address common health issues faced in disadvantaged urban neighborhoods in and around Greater Cleveland.
Researchers at the La Jolla Institute for Allergy & Immunology have proven - for the first time in human tissues - the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
April is Cesarean Awareness Month and the American College of Nurse-Midwives (ACNM) is renewing its call for Congressional hearings into the nation's rising Cesarean section rate and the impact on women's health and the overall health care system. Recent data indicates that as many 4 women in 10 gave birth by Cesarean in 2003, with an increasing percentage of first-time Cesareans being performed with no medical indication.
A major new international study published in the Journal of Hypertension has challenged traditional thinking by revealing that the thiazide-like diuretic indapamide SR (Natrilix SR) has equivalent efficacy to enalapril in reducing microalbuminuria (MA) in patients with type 2 diabetes.
› Verified 9 days ago
David A Hemry, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228 Fax: 907-562-6868 | |
Dr. Melinda Mcneal Rathkopf, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper Street, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228 Fax: 907-562-6868 | |
Dr. Stephen Neal Marks, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St Ste T4-054, Anchorage, AK 99508 Phone: 907-562-6228 Fax: 907-562-6868 | |
Jeffrey G Demain, M.D Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228 Fax: 907-562-6868 | |
Dr. Eric Albert Meier, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St, Suite T4-054, Anchorage, AK 99508 Phone: 907-562-6228 Fax: 907-562-6868 |